Ospedale Infermi di Rimini

Futó vizsgálatok

• Toboroz

  A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07518186· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

  NCT06994377· European Institute of Oncology· Forrás

• Toboroz

  Phase II single arm study with CABozantinib in Non-Small Cell Lung Cancer patients with MET deregulation

  NCT03911193· 2. fázis· Fondazione Ricerca Traslazionale· Forrás

• Toboroz

  MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The MITO 31 translational study.

  NCT04091204· 2. fázis· IRCCS Istituto Nazionale Tumori Fondazione Pascale· Forrás

• Toboroz

  Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  NCT06472245· 3. fázis· OSE Immunotherapeutics· Forrás

• Toboroz

  Master Framework For Relapse or Refractory Acute Myeloid Leukemia

  NCT06459024· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Fut, nem toboroz

  TRanscatheter Aortic-Valve Implantation With or Without On-site Cardiac Surgery: the TRACS Trial

  NCT05751577· Azienda Usl di Bologna· Forrás

• Toboroz

  Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

  NCT04662723· 4. fázis· Fondazione Schena· Forrás

• Fut, nem toboroz

  Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

  NCT05563220· 1/2. fázis· Stemline Therapeutics, Inc.· Forrás

• Toboroz

  Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

  NCT05009082· 3. fázis· AGO Study Group· Forrás

• Toboroz

  Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

  NCT06516406· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Forrás

• Fut, nem toboroz

  Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

  NCT04378855· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

• Toboroz

  Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

  NCT04300101· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Toboroz

  "Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL

  NCT06919393· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Fut, nem toboroz

  Functional Assessment in Elderly MI Patients With Multivessel Disease

  NCT03772743· Consorzio Futuro in Ricerca· Forrás

• Fut, nem toboroz

  Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma

  NCT03190525· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Petefészekrák2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Áttétes emlőrák1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Gyermekkori daganatok1 toboroz
• IgA-nefropátia1 toboroz
• Mielóma multiplex1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs

  NCT06316128· Heart Care Foundation· Forrás

• Lezárult

  Effect of Long-term Psoriasis on Patients' Life - CORONATE

  NCT05555953· AbbVie· Forrás

• Visszavonták

  To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer

  NCT05212701· 2. fázis· Dompé Farmaceutici S.p.A· Forrás

• Toboroz

  A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)

  NCT05001087· Fondazione EMN Italy Onlus· Forrás

• Leállították

  The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide

  NCT03804372· 2. fázis· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

• Lezárult

  A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma

  NCT03647124· Celgene· Forrás

• Lezárult

  Clinical and Laboratory Characteristics of Polycythemia Vera

  NCT06134102· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Forrás

• Lezárult

  TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

  NCT03596385· 4. fázis· Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III· Forrás

• Lezárult

  Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

  NCT03367299· 2. fázis· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

• Lezárult

  Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia

  NCT02388048· 2. fázis· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

• Leállították

  Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease

  NCT02579889· Biotronik SE & Co. KG· Forrás

• Lezárult

  Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia

  NCT02232386· 2. fázis· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

• Lezárult

  A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

  NCT02158858· 1/2. fázis· Constellation Pharmaceuticals· Forrás

• Lezárult

  Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

  NCT01699217· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

• Lezárult

  Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

  NCT01208766· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Fabry-betegség3 munka · 0 vizsgálat